Abstract
The NCCN-evidence-based oncology guidelines are consensus-based management documents, to ensure that all patients receive the most appropriate diagnosis, treatment and support services to achieve the best results. However, the use of these guidelines for decision-making by physicians in Spain is sometimes controversial, as treatments or diagnostic procedures are recommended which might not be authorised in our country, or other management options may exist. In March 2015, the ECO Foundation reached an agreement to translate and adapt the NCCN’s clinical practice guidelines in oncology for the Spanish sector. Consequently, ECO is the first European organization to reach an agreement of this type with the NCCN. This agreement will allow all agents involved in managing the cancer patients to have available guidelines that are adapted to the specific needs of Spain.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Casariego Vales E, Briones Pérez de la Blanca E, Costa Ribas C. Qué son las Guías de Práctica Clínica (GPC). http://www.fisterra.com/guias2/fmc/queson.pdf.
Scottish Intercollegiate Guidelines Network. Sign 50: a guideline developer’s handbook. (Internet) Edinburgh: SIGN; February 2001; January 2008. http://www.sign.ac.uk/guidelines/fulltext/50/. Accessed 12 Feb 2009.
Field MJ, Lohr KN, editors. Clinical practice guidelines: directions for a new Agency. Institute of Medicine, National Academic Press, Washington D.C.; 1990. p. 58.
Ministerio de Sanidad y Política Social. Estrategia en Cáncer del Sistema Nacional de Salud. SANIDAD 2010. http://www.msssi.gob.es/organizacion/sns/…/ActualizacionEstrategiaCancer.pdf.
Guía Salud. Biblioteca de Guías de Práctica Clínica del Sistema Nacional de Salud. http://www.guiasalud.es/.
Guías Clínicas SEOM. http://www.seom.org/es/publicaciones/guias-clinicas.
The European Society of Medical Oncology. http://www.esmo.org.
ASCO Guidelines. http://www.instituteforquality.org/practice-guidelines.
The National Comprehensive Cancer Network. http://www.nccn.org.
Zagouri F, Liakou P, Bartsch R, Peccatori FA, Tsigginou A, Dimitrakakis C et al. Discrepancies between ESMO and NCCN breast cancer guidelines: an appraisal. Breast 2015; 24: 513–523. http://www.elsevier.com/brst.
Protocolos y Guías de Práctica Clínica. http://www.medynet.com/…/Utilidad%20e%20Importacia%20del%20uso%20d.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The manuscript does not contain clinical studies or patient data.
Conflict of interest
A. Carrato serves on advisory boards from Roche, Merck, Amgen, Bayer and Servier. V. Guillem, C. Camps, E. Díaz-Rubio, and P. Gascón declare that they have no conflict of interest.
Research involving human participants and/or animals
This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Guillem, V., Camps, C., Carrato, A. et al. European edition of the NCCN clinical practice guidelines: relevance of the translation and adaptation into Spanish. Clin Transl Oncol 19, 288–290 (2017). https://doi.org/10.1007/s12094-016-1545-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-016-1545-6